|
SLC25A32 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.142800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.235200E-01 |
| Normal-vs-Stage2 |
9.590600E-01 |
| Normal-vs-Stage3 |
8.518800E-01 |
| Normal-vs-Stage4 |
9.390000E-01 |
| Stage1-vs-Stage2 |
8.980000E-01 |
| Stage1-vs-Stage3 |
9.899400E-01 |
| Stage1-vs-Stage4 |
9.219600E-01 |
| Stage2-vs-Stage3 |
9.222000E-01 |
| Stage2-vs-Stage4 |
9.855600E-01 |
| Stage3-vs-Stage4 |
9.299800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.319600E-01 |
| Normal-vs-AfricanAmerican |
8.026100E-02 |
| Normal-vs-Asian |
8.444800E-01 |
| Caucasian-vs-AfricanAmerican |
9.086400E-02 |
| Caucasian-vs-Asian |
8.566200E-01 |
| AfricanAmerican-vs-Asian |
3.501800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.281800E-01 |
| Normal-vs-Female |
2.937600E-01 |
| Male-vs-Female |
1.401750E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.800400E-02 |
| Normal-vs-Age(41-60Yrs) |
6.602800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.161000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.674600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.526300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.992300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.278400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.249000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.909400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.382400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.978400E-01 |
| Normal-vs-Grade 2 |
4.542400E-01 |
| Normal-vs-Grade 3 |
1.231190E-01 |
| Normal-vs-Grade 4 |
8.773800E-01 |
| Grade 1-vs-Grade 2 |
5.016000E-01 |
| Grade 1-vs-Grade 3 |
1.826990E-01 |
| Grade 1-vs-Grade 4 |
3.607400E-01 |
| Grade 2-vs-Grade 3 |
5.537100E-03 |
| Grade 2-vs-Grade 4 |
4.506600E-01 |
| Grade 3-vs-Grade 4 |
3.277400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.527800E-01 |
| Normal-vs-ccB subtype |
6.300200E-01 |
| ccA subtype-vs-ccB subtype |
6.582000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.629200E-01 |
| Normal-vs-N1 |
5.581000E-01 |
| N0-vs-N1 |
6.665000E-01 |
|
|
